This research aims to improve quality of life of patients with high grade glioma. Psychological variables which determine quality of life in this group will be determined. By means of collecting data on several questionnaires about concerns of this…
ID
Source
Brief title
Condition
- Nervous system neoplasms malignant and unspecified NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Quality of life
Secondary outcome
Not applicable
Background summary
Patients with high grade glioma experience psychosocial problems, which reduce
quality of life. There is no screening instrument available for this group to
register this uniformly in practice. Therefore, referring to the proper health
care worker for psychosocial problems remains difficult. With this study, we
aim to determine the psychosocial determinants of quality of life of patients
with high grade glioma. Based on this, we hope to develop a screening
instrument which can map the need for care. This instrument may include a
decision diagram, suited for the individual needs of the patient.
Study objective
This research aims to improve quality of life of patients with high grade
glioma. Psychological variables which determine quality of life in this group
will be determined. By means of collecting data on several questionnaires about
concerns of this group a screening instrument may be developed, named the
PDQ-HC (Head cancer), analogous to the PDQ-BC. Apart from generic questions,
there is attention for disease specific questions distinguishing the PDC-HC
from the PDQ-BC. Aim of this screening instrument is making an inventory of
psychosocial problems in a uniform and early manner, making a specific referral
possible. Specific psychosocial complaints can be signalled faster in a
structured manner, and can be reduced where possible. In this way, patients and
family need not be in a disproportionate emotional crisis for more time than
necessary.
Study design
prospective follow up study
Study burden and risks
Around diagnosis the MMSE will be administered to patients. This will take
approximately 15 minutes. Also, patiens and partners will be asked to fill in
some questionnaires around diagnosis, and 3, 6, 12, 18, and 24 months later.
This takes approximately 1 hour each time. If the research project raises any
questions, patients can contact GM Nefs, neuropsychologist i.o, and R. Van
Helvert, nursing specialist neuro-oncology.
Hilvarenbeekseweg 60
5022 GC Tilburg
Nederland
Hilvarenbeekseweg 60
5022 GC Tilburg
Nederland
Listed location countries
Age
Inclusion criteria
Age of 18 yrs. or older; mastery (speaking, reading, writing) of the Dutch language
Exclusion criteria
Cognitive deterioration (MMSE < 25), insufficient knowledge of the Dutch language, psychiatric illness.
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL20035.008.07 |